Delivery Order SPE2DB22D3016-SPE2DB25FAHQ2

Award Date 12/30/24
Potential Completion Date 1/22/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,903.03 firm fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,538.79 firm fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,093.47 firm fixed price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a specialty medication. The award was made on November 29, 2022, with an ultimate completion date of December 20, 2022. This contract is not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,538.79 firm-fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a specialty cancer medication. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen is the prime contractor and this award is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,871.50 firm fixed-price delivery order is for the supply of TAGRISSO 40 MG TABLET 30S, a specialty medication. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,341.08 firm fixed price delivery order is for the supply of TAGRISSO 40 MG TABLET 30S, a medical product. The award has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,709.09 fixed-price delivery order is for the supply of TAGRISSO 80 MG TABLET 30S, a medical product. The contract has a period of performance through December 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $42,033.24 firm-fixed-price delivery order is for the supply of TAGRISSO 40 MG TABLET 30S, a specialty medication. The contract has a completion date of September 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,508.31 fixed-price delivery order is for the supply of the specialty medication TAGRISSO 40 MG TABLET 30S. The contract has an ultimate completion date of November 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,871.50 firm fixed-price delivery order contract is for the delivery of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract is not designated with a set-aside. It is a child contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAHQ2
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,903.03 Firm Fixed Price Delivery Order contract provides TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, to support federal healthcare programs.

The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This IDC, which runs through November 2026, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award did not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any major subcontractors. The DLA, as a defense agency, is the funding organization for this contract.

Generated 3/31/25, 9:32 AM